Somerville Kurt F Vertex Pharmaceuticals Inc Transaction History
Somerville Kurt F
- $582 Million
- Q2 2024
A detailed history of Somerville Kurt F transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Somerville Kurt F holds 12,098 shares of VRTX stock, worth $5.69 Million. This represents 0.97% of its overall portfolio holdings.
Number of Shares
12,098
Previous 4,798
152.15%
Holding current value
$5.69 Million
Previous $2.01 Million
182.79%
% of portfolio
0.97%
Previous 0.35%
Shares
7 transactions
Others Institutions Holding VRTX
# of Institutions
1,714Shares Held
226MCall Options Held
1.21MPut Options Held
1.59M-
Capital World Investors Los Angeles, CA26.7MShares$12.6 Billion2.1% of portfolio
-
Vanguard Group Inc Valley Forge, PA23MShares$10.8 Billion0.21% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10 Billion0.23% of portfolio
-
State Street Corp Boston, MA11.7MShares$5.52 Billion0.24% of portfolio
-
Capital Research Global Investors Los Angeles, CA8.54MShares$4.02 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $121B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...